Question reference: S6W-04868
- Asked by: Dr. Sandesh Gulhane, MSP for Glasgow, Scottish Conservative and Unionist Party
- Date lodged: 6 December 2021 Registered interest
-
Current status: Answered by Humza Yousaf on 20 December 2021
Question
To ask the Scottish Government what information it has on the BC 007 treatment for long COVID, and whether it has considered trialling the treatment.
Answer
Following observations on a small number of patients with long COVID symptoms who received an experimental drug called BC 007 at the Universittsklinikum Erlangen in Germany, a trial of this drug as a potential therapy for long COVID is reportedly being planned by this research institute.
Applications from the Scottish clinical research community for research projects on possible treatments for long COVID can be submitted to the independent research funding committees operated by the Scottish Government’s Chief Scientist Office ( Response Mode Funding Schemes – Chief Scientist Office (scot.nhs.uk) ). Applications are assessed through independent expert peer review and funded based on the recommendations of the funding committees. No applications to trial BC 007 have been received for consideration.